10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $653,341 | -76.7% | 15,839 | -68.4% | 0.00% | -80.0% |
Q2 2023 | $2,803,715 | +64.6% | 50,175 | +64.0% | 0.01% | +66.7% |
Q1 2023 | $1,703,813 | +241.6% | 30,595 | +123.5% | 0.00% | +200.0% |
Q4 2022 | $498,715 | +58.3% | 13,689 | +23.4% | 0.00% | 0.0% |
Q3 2022 | $315,000 | -42.0% | 11,097 | -7.3% | 0.00% | 0.0% |
Q2 2022 | $543,000 | -40.7% | 11,970 | -6.9% | 0.00% | -50.0% |
Q1 2022 | $916,000 | -54.1% | 12,862 | -4.1% | 0.00% | -50.0% |
Q4 2021 | $1,995,000 | +11.3% | 13,414 | +8.8% | 0.00% | 0.0% |
Q3 2021 | $1,793,000 | -56.9% | 12,334 | -42.0% | 0.00% | -55.6% |
Q2 2021 | $4,159,000 | +132.6% | 21,261 | +115.6% | 0.01% | +125.0% |
Q1 2021 | $1,788,000 | -33.0% | 9,863 | -47.6% | 0.00% | -42.9% |
Q4 2020 | $2,667,000 | +12.4% | 18,837 | -1.0% | 0.01% | 0.0% |
Q3 2020 | $2,372,000 | +795.1% | 19,032 | +540.8% | 0.01% | +600.0% |
Q2 2020 | $265,000 | +46.4% | 2,970 | +2.0% | 0.00% | 0.0% |
Q1 2020 | $181,000 | – | 2,911 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |